Bruker Corporation (BRKR)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 113,100 | 304,900 | 352,100 | 401,600 | 427,200 | 319,100 | 319,100 | 311,500 | 296,600 | 274,900 | 273,900 | 282,000 | 277,100 | 270,300 | 237,500 | 204,000 | 157,800 | 157,500 | 164,500 | 176,900 |
| Total stockholders’ equity | US$ in thousands | 1,781,200 | 1,807,000 | 1,789,200 | 1,415,300 | 1,377,200 | 1,208,800 | 1,231,200 | 1,180,300 | 1,113,800 | 937,000 | 970,500 | 1,017,000 | 1,070,500 | 1,075,600 | 1,002,000 | 967,700 | 961,200 | 952,100 | 897,400 | 915,600 |
| ROE | 6.35% | 16.87% | 19.68% | 28.38% | 31.02% | 26.40% | 25.92% | 26.39% | 26.63% | 29.34% | 28.22% | 27.73% | 25.89% | 25.13% | 23.70% | 21.08% | 16.42% | 16.54% | 18.33% | 19.32% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $113,100K ÷ $1,781,200K
= 6.35%
Bruker Corporation's return on equity (ROE) has shown a fluctuating trend over the period from March 31, 2020, to December 31, 2024. The ROE started at 19.32% in March 2020 and experienced some fluctuations before reaching a peak at 31.02% in December 2023. However, the ROE declined in the subsequent quarters, notably dropping to 6.35% by the end of December 2024.
The variations in ROE can indicate changes in the profitability and efficiency of Bruker Corporation in generating returns for its shareholders relative to the equity invested in the company. A declining ROE could suggest issues with operational efficiency, declining profitability, or inefficient use of shareholder equity.
It would be important for stakeholders and analysts to further investigate the reasons behind the fluctuations in ROE to assess the company's overall financial performance and sustainability over time. The trend of declining ROE in the latter period raises concerns that warrant a closer examination of Bruker Corporation's financial health and strategic decisions.
Peer comparison
Dec 31, 2024